Zobrazeno 1 - 10
of 538
pro vyhledávání: '"MJ Murray"'
G549(P) A fifteen-year review of paediatric ovarian immature teratoma and its management (2002–2017)
Publikováno v:
BRITISH SOCIETY OF HAEMATOLOGY AND UK CHILDREN’S CANCER AND LEUKAEMIA CARE.
Aims Paediatric ovarian immature teratoma (IT) is a rare tumour, considered largely benign in its behaviour. Surgery alone is the standard therapy regardless of stage (S; I-IV) or grade (G; 1–3); in contrast, adult women with the disease are report
Publikováno v:
In Fertility and Sterility November 2022 118(5) Supplement:e13-e14
Publikováno v:
Anesthesia & Analgesia. 86:11SCA
Publikováno v:
Anesthesia & Analgesia. 86:91S
Autor:
Mahmood S; Department of Paediatric Haematology and Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; University of Cambridge School of Clinical Medicine, Cambridge, UK., Leiter SM; Department of Paediatric Haematology and Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Department of Paediatrics, University of Cambridge, Cambridge, UK.; Wellcome Sanger Institute, Hinxton, Cambridgeshire, UK., Phyu P; Department of Radiology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Craven C; Department of Neurosurgery, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Horan G; Department of Radiation Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Gains J; Department of Radiation Oncology, Proton Beam Therapy Centre, University College London Hospital, London, UK., Briggs M; Department of Neuropathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Blanco E; Department of Paediatric Haematology and Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Behjati S; Department of Paediatric Haematology and Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Wellcome Sanger Institute, Hinxton, Cambridgeshire, UK., Watkins J; East Genomic Laboratory Hub (GLH) Genetics Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Tadross JA; East Genomic Laboratory Hub (GLH) Genetics Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Medical Research Council Metabolic Diseases Unit, Institute of Metabolic Science Metabolic Research Laboratories, University of Cambridge, Cambridge, UK., Roberts T; East Genomic Laboratory Hub (GLH) Genetics Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Trotman J; East Genomic Laboratory Hub (GLH) Genetics Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Tarpey P; East Genomic Laboratory Hub (GLH) Genetics Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Armstrong R; Department of Medical Genetics, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Murray MJ; Department of Paediatric Haematology and Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Department of Pathology, University of Cambridge, Cambridge, UK.
Publikováno v:
Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Dec; Vol. 71 (12), pp. e31368. Date of Electronic Publication: 2024 Oct 08.
Autor:
Ferraresso M; Department of Pathology, University of Cambridge, UK., Bailey S; Department of Pathology, University of Cambridge, UK., Alonso-Crisostomo L; Department of Pathology, University of Cambridge, UK., Ward D; Department of Pathology, University of Cambridge, UK., Panayi C; Department of Pathology, University of Cambridge, UK., Scurlock ZGL; Department of Pathology, University of Cambridge, UK., Saini HK; EMBL-European Bioinformatics Institute (EMBL-EBI), Cambridge, UK., Smith SP; Department of Pathology, University of Cambridge, UK., Nicholson JC; Department of Paediatrics, University of Cambridge, Cambridge University Hospitals NHS Foundation Trust, UK.; Department of Paediatric Haematology and Oncology, Cambridge University Hospitals NHS Foundation Trust, UK., Enright AJ; Department of Pathology, University of Cambridge, UK., Scarpini CG; Department of Pathology, University of Cambridge, UK., Coleman N; Department of Pathology, University of Cambridge, UK.; Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, UK., Murray MJ; Department of Pathology, University of Cambridge, UK.; Department of Paediatric Haematology and Oncology, Cambridge University Hospitals NHS Foundation Trust, UK.
Publikováno v:
Molecular oncology [Mol Oncol] 2024 Nov 10. Date of Electronic Publication: 2024 Nov 10.
Autor:
Bishop M; Wellcome Connecting Science, Wellcome Genome Campus, Hinxton, UK. mb44@sanger.ac.uk., Vedi A; Department of Paediatric Haematology and Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Department of Paediatrics, University of Cambridge, Cambridge, UK., Bowdin S; NHS East Genomic Laboratory Hub, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Armstrong R; Department of Medical Genetics, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Bartram J; Department of Paediatric Haematology and Oncology, Great Ormond Street Hospital for Children NHS Trust, London, UK., Bentley D; Illumina, Cambridge Ltd, Cambridge, UK., Ross M; Illumina, Cambridge Ltd, Cambridge, UK., Hook CE; Department of Pathology, University of Cambridge, Cambridge, UK.; Department of Paediatric Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Yin Chung BH; Department of Paediatrics and Adolescent Medicine, School of Clinical Medicine, Li Ka Shing, Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong SAR, China.; Hong Kong Genome Institute, Hong Kong, Hong Kong SAR, China., Moss P; Genomics England, London, UK., Rowitch DH; Department of Paediatrics, University of Cambridge, Cambridge, UK., Tarpey P; NHS East Genomic Laboratory Hub, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Behjati S; Department of Paediatric Haematology and Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Department of Paediatrics, University of Cambridge, Cambridge, UK.; Wellcome Sanger Institute, Hinxton, Cambridge, UK., Murray MJ; Department of Paediatric Haematology and Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Department of Pathology, University of Cambridge, Cambridge, UK.
Publikováno v:
BMC medical education [BMC Med Educ] 2024 Nov 06; Vol. 24 (1), pp. 1273. Date of Electronic Publication: 2024 Nov 06.
Autor:
Ní Leathlobhair M; Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK. mnileathlobhair@gmail.com.; Ludwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK. mnileathlobhair@gmail.com.; Department of Microbiology, Moyne Institute of Preventive Medicine, School of Genetics and Microbiology, Trinity College Dublin, Dublin, Ireland. mnileathlobhair@gmail.com., Frangou A; Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany., Kinnersley B; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.; University College London Cancer Institute, 72 Huntley Street, London, UK., Cornish AJ; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK., Chubb D; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK., Lakatos E; Department of Mathematical Sciences, Chalmers University of Technology and University of Gothenburg, Gothenburg, Sweden., Arumugam P; Genomics England, London, UK., Gruber AJ; Department of Biology, University of Konstanz, Universitaetsstrasse 10, D-78464, Konstanz, Germany., Law P; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK., Tapinos A; Manchester Cancer Research Centre, The University of Manchester, Manchester, UK., Jakobsdottir GM; Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.; Christie Hospital, The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK., Peneva I; Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Sahli A; Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK., Smyth EM; Department of Microbiology, Moyne Institute of Preventive Medicine, School of Genetics and Microbiology, Trinity College Dublin, Dublin, Ireland., Ball RY; Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK., Sylva R; Guy's and St Thomas' NHS Foundation Trust, London, UK., Benes K; Department of Pathology, The Royal Wolverhampton NHS Trust, Wolverhampton, UK., Stark D; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK., Young RJ; Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Lee ATJ; Christie Hospital, The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK., Wolverson V; Genomics England, London, UK., Houlston RS; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK., Sosinsky A; Genomics England, London, UK., Protheroe A; Department of Oncology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Murray MJ; Department of Paediatric Haematology and Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. mjm16@cam.ac.uk.; Department of Pathology, University of Cambridge, Cambridge, UK. mjm16@cam.ac.uk., Wedge DC; Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK. david.wedge@manchester.ac.uk.; Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK. david.wedge@manchester.ac.uk.; Christie Hospital, The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK. david.wedge@manchester.ac.uk., Verrill C; NIHR Oxford Biomedical Research Centre, Oxford, UK. clare.verrill@ouh.nhs.uk.; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK. clare.verrill@ouh.nhs.uk.
Publikováno v:
Nature communications [Nat Commun] 2024 Oct 26; Vol. 15 (1), pp. 9247. Date of Electronic Publication: 2024 Oct 26.
Autor:
Hendriks AEJ; Department of Paediatric Endocrinology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK & Department of Paediatrics, University of Cambridge, Cambridge, UK., Burns C; Department of Paediatric Haematology and Oncology, Cambridge University Hospital, Cambridge, UK., Fleming B; Department of Radiology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Harper I; Department of Nuclear Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Hook E; Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Armstrong R; Department of Medical Genetics, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Pamporaki C; Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany., Eisenhofer G; Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany., Murray MJ; Department of Paediatric Haematology and Oncology, Cambridge University Hospital, Cambridge, UK.; Department of Pathology, University of Cambridge, Cambridge, UK., Casey RT; Department of Endocrinology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Department of Medical Genetics, Cambridge University, Cambridge, UK.
Publikováno v:
The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2024 Aug 31. Date of Electronic Publication: 2024 Aug 31.